Talk to an expert
Envelope Linkedin

Explore Starodub latest resources

Get in touch
View whitepapers
  • Updates

Is Your Post-Market Surveillance (PMS) System Fully MDR-Compliant? 
  • Updates

Regulatory Affairs, Drug Development & AI: Navigating the New EMA Guidance
  • Updates

Change in distribution Direct Healthcare Professional Communication in the Netherlands
  • Updates

Key Outcomes of LSH Dutch Mission to Japan: New Partnerships to Support Market Entry
  • Updates

Article 61(10) of MDR: A Pathway for Medical Device Software?
  • Updates

The Compliance Compass: Guiding Clinical Investigations for Medical Devices through ISO 14155 and MDR
Load more updates

Our expertise

Starodub Whitepapers

Approaches to include drug substance quality information in a drug product application (June 2022)

How to select a cell line to produce a biosimilar (June 2021)

Combination products in the EU MDR (May 2021)

News on the Postponement of the EU Medical Device Regulation, Corrigenda and MDCG guidance (June 2020)

EU MDR impact on importers and distributors (March 2020)

Biopharmaceutical products – Do you have your reference standard program in place? (December 2019)

Radiopharmaceuticals – How to Register in EU? (October 2019)

Is your Active Pharmaceutical Ingredient quality control strategy up to standard? (July 2019)

What is new under the EU MDR for software manufacturers? (December 2018)

Company

Services

Resources

Contact us

Our Office
Industriestraat 14
5391 BR Nuland
The Netherlands
Email
[email protected]
Envelope Linkedin

Starodub – a team of experts in regulatory affairs

Copyright © 2024. All Rights Reserved.

Konstantin Simočenko
Senior RA Manager

Let's Connect

Talk to an expert